<p><b>a</b>, Body weights of male <i>db/db</i> mice treated with vehicle (empty diamonds) or P1736 (150mg/kg, solid square) or metformin (solid triangle) for 15 days. Body weight was measured daily and recorded. <b>b</b>, Change in the weights of <i>db/db</i> mice treated with vehicle(empty diamonds) or P1736 (5 mg/kg twice daily, solid squares) or rosiglitazone (5 mg/kg, solid triangles) for 15 days. Data are expressed as Mean ± SEM for 7 - 10 animals per treatment group. * p< 0.05 compared to vehicle.</p
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
Insulin resistance is a characteristic feature of Type 2 diabetes. Insulin resistance has also been ...
<p>A: grip strength of the mice during treatment in each group. B: time to fall from an accelerating...
<p><b>a</b>, Plasma glucose levels in male <i>db/db</i> mice that received once daily oral doses of ...
<p>A: gastrocnemius weight of the mice during treatment in each group. B: quadriceps weight of the m...
<p>Diabetic mice were treated with BPs (30 and 60 mg/kg/day), glyburide (7.2 mg/kg/day), or vehicle ...
<p>The animals were dosed intraperitoneally once daily with metformin (closed triangles) or twice da...
<p>Male C57BL6/J mice were fed with either a standard chow diet (lean) or a high-fat diet (obese) du...
<p>Data represent the means ± SEM for 5–10 mice.</p>***<p>p<0.001 compared with lean group;</p>#<p>p...
<p>Each point represents the mean ± SD for 10 animals in each group. *P<0.05, **P<0.01vs. Normal.</p
<p>Effect of feeding 180 mg/kg 55P0110 to 9 weeks-old (<b>A</b>) or 90 mg/kg 55P0110 to 12 weeks-old...
<p>Vehicle, pioglitazone (30 mg/kg), gliclazide (8 mg/kg), metformin (200 mg/kg), sitagliptin (10 mg...
Background: Metformin was approved by FDA in 1994 for the treatment of type II diabetes mellitus. Du...
<p><i>db/m</i>, nondiabetic control mice; <i>db/db</i>, untreated diabetic mice; <i>db/db</i>+0.1 da...
The studies were performed to investigate the physiological characteristics of non-obese diabetic (N...
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
Insulin resistance is a characteristic feature of Type 2 diabetes. Insulin resistance has also been ...
<p>A: grip strength of the mice during treatment in each group. B: time to fall from an accelerating...
<p><b>a</b>, Plasma glucose levels in male <i>db/db</i> mice that received once daily oral doses of ...
<p>A: gastrocnemius weight of the mice during treatment in each group. B: quadriceps weight of the m...
<p>Diabetic mice were treated with BPs (30 and 60 mg/kg/day), glyburide (7.2 mg/kg/day), or vehicle ...
<p>The animals were dosed intraperitoneally once daily with metformin (closed triangles) or twice da...
<p>Male C57BL6/J mice were fed with either a standard chow diet (lean) or a high-fat diet (obese) du...
<p>Data represent the means ± SEM for 5–10 mice.</p>***<p>p<0.001 compared with lean group;</p>#<p>p...
<p>Each point represents the mean ± SD for 10 animals in each group. *P<0.05, **P<0.01vs. Normal.</p
<p>Effect of feeding 180 mg/kg 55P0110 to 9 weeks-old (<b>A</b>) or 90 mg/kg 55P0110 to 12 weeks-old...
<p>Vehicle, pioglitazone (30 mg/kg), gliclazide (8 mg/kg), metformin (200 mg/kg), sitagliptin (10 mg...
Background: Metformin was approved by FDA in 1994 for the treatment of type II diabetes mellitus. Du...
<p><i>db/m</i>, nondiabetic control mice; <i>db/db</i>, untreated diabetic mice; <i>db/db</i>+0.1 da...
The studies were performed to investigate the physiological characteristics of non-obese diabetic (N...
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
Insulin resistance is a characteristic feature of Type 2 diabetes. Insulin resistance has also been ...
<p>A: grip strength of the mice during treatment in each group. B: time to fall from an accelerating...